Interactive Software “Isotonic Design using Normalized Equivalent Toxicity Score (ID-NETS©TM)” for Cancer Phase I Clinical Trials

by Chen, Zhengjia, Wang, Zhibo, Wang, Haibin, Owonikoko, Taofeek K, Kowalski, Jeanne, Khuri, Fadlo R
Published 2013

Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing

by Oh, You-Take, Deng, Jiusheng, Yue, Ping, Owonikoko, Taofeek K., Khuri, Fadlo R., Sun, Shi-Yong
Published 2015

GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth

by Koo, Junghui, Wang, Xuerong, Owonikoko, Taofeek K., Ramalingam, Suresh S., Khuri, Fadlo R., Sun, Shi-Yong
Published 2015

The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo

by Xu, Cheng-Xiong, Li, Yikun, Yue, Ping, Owonikoko, Taofeek K., Ramalingam, Suresh S., Khuri, Fadlo R., Sun, Shi-Yong
Published 2011

Rising Incidence of Mucosal Melanoma of the Head and Neck in the United States

by Marcus, David M., Marcus, Rebecca P., Prabhu, Roshan S., Owonikoko, Taofeek K., Lawson, David H., Switchenko, Jeffrey, Beitler, Jonathan J.
Published 2012

Bcl2 inhibits recruitment of Mre11 complex to DNA double-strand breaks in response to high-linear energy transfer radiation

by Xie, Maohua, Park, Dongkyoo, You, Shuo, Li, Rui, Owonikoko, Taofeek K., Wang, Ya, Doetsch, Paul W., Deng, Xingming
Published 2015

Statistical learning methods as a preprocessing step for survival analysis: evaluation of concept using lung cancer data

by Behera, Madhusmita, Fowler, Erin E, Owonikoko, Taofeek K, Land, Walker H, Mayfield, William, Chen, Zhengjia, Khuri, Fadlo R, Ramalingam, Suresh S, Heine, John J
Published 2011

A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer

by Chiappori, Alberto A., Otterson, Gregory A., Dowlati, Afshin, Traynor, Anne M., Horn, Leora, Owonikoko, Taofeek K., Ross, Helen J., Hann, Christine L., Abu Hejleh, Taher, Nieva, Jorge, Zhao, Xiuhua, Schell, Michael, Sullivan, Daniel M.
Published 2016

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

by Owonikoko, Taofeek K., Zhang, Guojing, Kim, Hyun S., Stinson, Renea M., Bechara, Rabih, Zhang, Chao, Chen, Zhengjia, Saba, Nabil F., Pakkala, Suchita, Pillai, Rathi, Deng, Xingming, Sun, Shi-Yong, Rossi, Michael R., Sica, Gabriel L., Ramalingam, Suresh S., Khuri, Fadlo R.
Published 2016

Small Molecule Bax Agonists for Cancer Therapy

by Xin, Meiguo, Li, Rui, Xie, Maohua, Park, Dongkyoo, Owonikoko, Taofeek K., Sica, Gabriel L., Corsino, Patrick E., Zhou, Jia, Ding, Chunyong, White, Mark A., Magis, Andrew T., Ramalingam, Suresh S., Curran, Walter J., Khuri, Fadlo R., Deng, Xingming
Published 2014

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a...

by Neal, Joel W., Dahlberg, Suzanne E., Wakelee, Heather A., Aisner, Seena C., Bowden, Michaela, Huang, Ying, Carbone, David P., Gerstner, Gregory J., Lerner, Rachel E., Rubin, Jerome L., Owonikoko, Taofeek K., Stella, Philip J., Steen, Preston D., Khalid, Ahmed Ali, Ramalingam, Suresh S.
Published 2016

Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer

by Owonikoko, Taofeek K, Zhang, Guojing, Deng, Xingming, Rossi, Michael R, Switchenko, Jeffrey M, Doho, Gregory H, Chen, Zhengjia, Kim, Sungjin, Strychor, Sandy, Christner, Susan M, Beumer, Jan, Li, Chunyang, Yue, Ping, Chen, Alice, Sica, Gabriel L, Ramalingam, Suresh S, Kowalski, Jeanne, Khuri, Fadlo R, Sun, Shi-Yong
Published 2014